When will real benefits for minority patients be realized with A2→b transplants?

Transplantation

Volumn 89, Issue 11, 2010, Pages 1310-1311

  Nelson, Paul W ^a,b   Bryan, Christopher F ^a  

^a Midwest Transplant Network   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; BLOOD GROUP A; BLOOD GROUP A2; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HISTOCOMPATIBILITY; HUMAN; INCIDENCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MINORITY GROUP; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; SURVIVAL RATE; SURVIVAL TIME;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; DESENSITIZATION, IMMUNOLOGIC; HUMANS; KIDNEY TRANSPLANTATION; MINORITY GROUPS; TRANSPLANTATION IMMUNOLOGY; WAITING LISTS;

EID: 77953603235     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181dc734f     Document Type: Note

References (13)

1. Gaston RS. Addressing minority issues in renal transplantation: Is more equitable access an achievable goal? Am J Transplant 2002; 2: 1.
2. Nelson PW, Shield CF, Muruve NA, et al. Increased accesstotransplan- tation for blood group B cadaveric waiting list candidates by using A2 kidneys: Time for a new national system. Am J Transplant 2002; 2: 94.
3. Bryan CF, Winklhofer FT, Murillo D, et al. Improving access to kidney transplantation without decreasing graft survival: Long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation 2005; 80: 75.
4. Bryan CF, Nelson PW, Shield CF, et al. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant 2007; 7: 1181.
5. Williams WW, Cherickh WS, Young C, et al. Update on the OPTN/UNOS national voluntary variance to allocate A2/A2B deceased donor kidneys to blood group B candidates. Am J Transplant 2008; 6(suppl): 30.
6. Hurst F, Imran S, Abbott K, et al. Transplantation of A2 kidneys into B and O recipients leads to reduction inwaiting time: USRDS experience. Transplantation 2010; 89: XX.
7. Hanto DW, Brunt EM, Goss JA, et al. Accelerated acute rejection of an A2 renal allograft in an O recipient: Association with an increase in anti-A2 antibodies. Transplantation 1993; 56: 743.
8. Bryan CF, McDonald SB, Harrell KM, et al. A method comparison for performing the anti-A titer assay for transplantation of A2 kidneys into B and O patients. Transplantation 2000; 69: 133.
9. Bariety J, Oriol R, Hinglais N, et al. Distributionof blood group antigen A in normal and pathologic human kidneys. Kidney Int 1980; 17: 820.
10. Bryan CF, Polesky H, Eisenbrey AB, et al. Implications of ABO error rates in proficiency testing for solid organ transplantation. Transplantation 2006; 82: 733.
11. Fishbein T, Emre S,Guy SR, et al. Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation 1999: 67; 1071.
12. Skogsberg U, Breimer ME, Friman S, et al. Adult ABO-incompatible liver transplantation using A2 and B donors. Xenotransplantation 2006; 13: 154
13. OPTN/UNOS Kidney allocation concepts: Request for information. 2008; 30.